Hot Products
0102030405
Benfotiamine: China Suppliers Factory Offering High Bioavailability Lipid-Soluble Vitamin B1
C19H23N4O6PS
ⓘ
Description
As a synthetic derivative of vitamin B1 (thiamine), benfotiamine significantly surpasses ordinary vitamin B1 in bioavailability, targeting and clinical efficacy through structural optimization and pharmacokinetic improvement. The specific advantages are as follows:
1
Structural Innovation: Lipid-Soluble Modification Breaks Through Absorption Limitations
Ordinary vitamin B1 (thiamine) is a water-soluble molecule that relies on intestinal sodium-dependent carriers (ThTr1/2) for active transport. It has a low absorption rate (<5%) and is easily saturated. High doses are easily excreted.
Benfotiamine is converted into a lipid-soluble prodrug by introducing benzoyl and phosphate groups (structural formula C19H23N4O6PS), which can bypass carrier restrictions and directly penetrate intestinal mucosal cells through passive diffusion.
>80%
Absorption Efficiency of Benfotiamine
<5%
Absorption Rate of Ordinary B1
3–5×
Higher Bioavailability vs. Ordinary B1 J Clin Pharmacol, 2008
2
Pharmacokinetic Advantages: Long-Term Effect and Tissue Targeting
Ordinary B1 has a short half-life in the blood (about 3.5 hours) and is easily cleared quickly by the kidneys. Benfotiamine is hydrolyzed into active thiamine by phosphatase in the body and further converted into thiamine pyrophosphate (TPP).
- ✓ Its lipid solubility makes it easier to accumulate in the phospholipid layer of the cell membrane, prolonging the duration of action (half-life >6 hours).
- ✓ Its ability to penetrate the blood-brain barrier and nerve sheath is 8–10 times that of ordinary B1 Neurochem Res, 2016, effectively acting on the central and peripheral nervous systems.
3
Metabolic Regulation: Multi-Target Inhibition of Glucotoxic Damage
In a hyperglycemic environment, ordinary B1 is difficult to effectively inhibit abnormal glucose metabolism pathways due to poor tissue permeability. Benfotiamine shows unique advantages through the following mechanisms:
- ■ Blocking AGEs generation: inhibiting hexosamine and polyol pathways, reducing the accumulation of advanced glycation end products (AGEs), and alleviating axonal damage in diabetic neuropathy. Diabetes, 2010
- ■ Anti-inflammatory and antioxidant: downregulating the activity of NF-κB and TXNIP/NLRP3 inflammasomes, reducing inflammatory factors such as IL-6 and TNF-α, while enhancing glutathione reductase activity and alleviating oxidative stress.
- ■ Mitochondrial protection: restoring the function of pyruvate dehydrogenase complex (PDH), improving the efficiency of tricarboxylic acid cycle, and reducing lactic acid accumulation.
4
Clinical Efficacy: High-Dose Tolerance and Deep Repair
Ordinary B1 requires extremely high doses (≥300 mg/day) to treat diabetic neuropathy, but its efficacy is limited due to its absorption rate. Benfotiamine can stably increase tissue TPP concentration within the dose range of 150–600 mg/day.
+2.1 m/s
Improvement in Nerve Conduction Velocity vs. Placebo
−40%
Reduction in Pain Scores (VAS)
Safe
No Liver/Kidney Toxicity Reported Diabetes Care, 2005
5
Stability and Compatibility of Preparations
Benfotiamine is significantly more stable than ordinary B1 in an acidic environment (pH 2.0–4.0):
- ✓ Degradation rate <5% for Benfotiamine vs. >30% for ordinary B1 under acidic conditions.
- ✓ Compatible with a variety of multivitamins or drug preparations.
- ✓ Its lipid-soluble properties support the development of delivery systems such as nanoemulsions and liposomes, further improving the efficiency of targeted delivery.
❓
Frequently Asked Questions (FAQ)
Q
What is benfotiamine and how does it differ from ordinary vitamin B1?
Benfotiamine is a synthetic, lipid-soluble derivative of vitamin B1 (thiamine). Unlike ordinary thiamine, which is water-soluble and relies on limited intestinal carriers for absorption, benfotiamine can passively diffuse through intestinal mucosal cells, achieving over 80% absorption efficiency — 3 to 5 times the bioavailability of standard B1.
Q
Why is benfotiamine more effective for nerve-related conditions than regular B1?
Benfotiamine's lipid-soluble structure allows it to penetrate the blood-brain barrier and nerve sheaths 8–10 times more effectively than ordinary B1. This enables it to directly act on both the central and peripheral nervous systems, making it particularly beneficial for conditions such as diabetic neuropathy.
Q
How does benfotiamine help protect against diabetic complications?
Benfotiamine works through multiple pathways: it blocks the formation of advanced glycation end products (AGEs), downregulates inflammatory mediators such as NF-κB, IL-6, and TNF-α, enhances antioxidant defenses via glutathione reductase, and restores mitochondrial energy metabolism — all of which help protect tissues from high-glucose-induced damage.
Q
What is the recommended dosage range for benfotiamine in clinical use?
Clinical trials have used benfotiamine in the range of 150–600 mg per day. Within this range, it has been shown to stably increase tissue thiamine pyrophosphate (TPP) concentrations, improve nerve conduction velocity by approximately 2.1 m/s versus placebo, and reduce pain scores (VAS) by up to 40%, without reports of liver or kidney toxicity.
Q
Is benfotiamine stable in acidic environments and compatible with other supplements?
Yes. Benfotiamine demonstrates excellent stability in acidic conditions (pH 2.0–4.0), with a degradation rate of less than 5%, compared to over 30% for ordinary B1. It is compatible with a wide range of multivitamin formulas and pharmaceutical preparations, and its lipid-soluble nature also makes it suitable for advanced delivery systems such as nanoemulsions and liposomes.
Q
What is the chemical formula of benfotiamine and what does its structure include?
Benfotiamine has the molecular formula C19H23N4O6PS. Its structure is based on thiamine but modified with the addition of benzoyl and phosphate groups. These modifications convert it into a lipid-soluble prodrug that bypasses the saturable intestinal carrier transport system, enabling far superior absorption and tissue distribution compared to standard thiamine.